We are live on ! Find out more
FCMI

Foresite Capital Management III Portfolio holdings

AUM $37.9M Turnover 0%
1-Year Est. Return 6.87%
This Fund
S&P 500
This Quarter Est. Return
+54.36%
1 Year Est. Return
-6.87%
3 Year Est. Return
+444.07%
5 Year Est. Return
+547.28%
10 Year Est. Return
–
AUM
$37.9M
AUM Growth
+$10.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
1.3 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1.3 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ASND icon
1
Ascendis Pharma A/S
ASND
$15.4B
$13.8M 36.44%
133,691
– –
2021 Q4
3 quarters
VRNA
2
DELISTED
Verona Pharma
VRNA
$11.4M 29.98%
1,111,112
– –
2021 Q1
6 quarters
NTRA icon
3
Natera
NTRA
$58.7B
$6.97M 18.41%
159,160
– –
2021 Q4
3 quarters
CBAY icon
4
DELISTED
Cymabay Therapeutics
CBAY
$5.75M 15.17%
1,641,804
– –
2020 Q2
9 quarters

Similar funds

Foresite Capital Management III's Q3 2022 Portfolio in Review

As of Q3 2022, Foresite Capital Management III held 4 positions worth $37.9M, up 37% from $27.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Foresite Capital Management III opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management III's ten largest holdings make up 100% of its $37.9M portfolio in Q3 2022.
  • Foresite Capital Management III opened 0 new positions and closed 0 in Q3 2022.
  • Foresite Capital Management III's portfolio value rose 37% quarter-over-quarter to $37.9M.

Based on Foresite Capital Management III's 13F filing for Q3 2022, filed 14 Nov 2022.